Long-term oncological outcomes and toxicity in 597 men aged ≤60 years at time of low-dose-rate brachytherapy for localised prostate cancer.

@article{Langley2018LongtermOO,
  title={Long-term oncological outcomes and toxicity in 597 men aged ≤60 years at time of low-dose-rate brachytherapy for localised prostate cancer.},
  author={Stephen E M Langley and Ricardo de Brito Soares and Jennifer Uribe and Santiago Uribe-Lewis and Julian Money-Kyrle and Carla Perna and Sara Jane Khaksar and Robert W Laing},
  journal={BJU international},
  year={2018},
  volume={121 1},
  pages={38-45}
}
OBJECTIVES To report oncological and functional outcomes of men treated with low-dose-rate (LDR) prostate brachytherapy aged ≤60 years at time of treatment. PATIENTS AND METHODS Of 3262 patients treated with LDR brachytherapy at our centre up to June 2016, we retrospectively identified 597 patients aged ≤60 years at treatment with ≥3-years post… CONTINUE READING